10-((4-piperonyl-1-piperazinyl)acetyl)phenothiazine,
fenoverine,
Spasmopriv,
Fenoverine,
Spasmopriv,
37561-27-6,
Fenoverine [INN:DCF],
Fenoverinum [INN-Latin],
Fenoverina [INN-Spanish],
UNII-N274ZQ6PZJ,
EINECS 253-552-1,
N274ZQ6PZJ,
C26H25N3O3S,
10-((4-Piperonyl-1-piperazinyl)acetyl)phenothiazine,
NCGC00160678-01,
10-((4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl)acetyl)-10H-phenothiazine,
10H-Phenothiazine, 10-((4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)acetyl)-,
DSSTox_CID_26296,
DSSTox_RID_81521,
DSSTox_GSID_46296,
10-[(4-piperonyl-1-piperazinyl)acetyl]phenothiazine,
Fenoverina,
Fenoverinum,
2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-1-phenothiazin-10-ylethanone,
CAS-37561-27-6,
Fenoverine (INN),
AC1L2HF1,
AC1Q5K0Q,
SCHEMBL25003,
CHEMBL1512949,
DTXSID8046296,
CTK4H8403,
CHEBI:135744,
Tox21_111981,
STK210707,
ZINC19899628,
AKOS001778935,
Tox21_111981_1,
CCG-124308,
DB13042,
MCULE-4447032499,
ACM37561276,
NCGC00160678-03,
CC-28392,
LS-105245,
FT-0754438,
ST50161536,
D07095,
C-23691,
BRD-K77564118-001-01-5,
10-{[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]acetyl}-10H-phenothiazine,
2-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)-1-(10H-phenothiazin-10-yl)ethanone,
2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-1-(10H-phenothiazin-10-yl)ethanone,
Ethanone,2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-1-(10H-phenothiazin-10-yl)-,
2-[4-(2H-benzo[3,4-d]1,3-dioxolan-5-ylmethyl)piperazinyl]-1-phenothiazin-10-yl ethan-1-one,
Fenoverine [DCF:INN],
CID72098,
AR-1C0076,
C26-H25-N3-O3-S,
C048314,
2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-1-phenothia,
10-[[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]acetyl]-10H-phenothiazine,
10H-Phenothiazine, 10-[[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]acetyl]-,
2-[4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl]-1-(10H-phenothiazin-10-yl)ethanone,
39640-08-9,